Medicenna Announces Management - GuruFocus.com
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Stay updated with breaking news from Mann Muhsin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Phase 1/2 ABILITY study of MDNA11 remains on track for an update on additional safety pharmacokinetic (PK), and pharmacodynamic (PD) data in low-dose...
— Phase 1/2 ABILITY Study of MDNA11 in patients with advanced solid tumors remains on track for initiation in the third quarter of calendar 2021
Novartis has lost another NIBR exec to the call of biotech. Blueprint Medicines has added another BMS vet to its roster. And Iovance quietly announced its CEO's departure Wednesday.